Madrid / Barcelona / Krakow / Boston / Stockholm / Canberra / Seville / /
Company
Cambridge University Press / Andalusian Agency for Health Technology Assessment / Karolinska Hospital / PET / INAHTA / Agency for Health Technology Assessment / Catalan Agency for Health Technology Assessment / Massachusetts 02130 INTL / /
Country
Germany / Netherlands / Poland / Belgium / France / United States / Canada / Australia / Israel / Denmark / / /
Event
FDA Phase / M&A / /
Facility
University Hospital Department / University Hospital / Uppsala University Hospital / Institute of Technology Assessment / cyclotron facility / Institute of Applied Health Sciences / /
IndustryTerm
clinical applications / installed systems / cost diagnostic technologies / health technology assessment / healthcare systems / use health technology assessment / beneficial diagnostic imaging test / cost diagnostic technology / scarce healthcare resources / potential beneficial diagnostic technologies / patient management / healthcare resources / hybrid systems / diagnostic imaging modalities / /
MedicalCondition
unknown primary tumors / lymphoma / Colorectal cancer / head and neck cancer no . of / SMM Lung cancer / Thyroid cancer Breast cancer Dementia Cardiology Pancreatic carcinoma Tumors / melanoma / recurrent disease / cancer / tumors / chronic skeletal infection / cancer Tumors / myeloma / testicular cancer / Lung cancer / /
Organization
National Association of Statutory Health Insurance Physicians Department of HTA / INAHTA Executive Board / Cambridge University / Veterans Health Administration / Finnish Office / French National Agency for Accreditation and Evaluation / University Hospital / ICTAHC MSAC / Medical Technology Unit / Netherlands Organisation for Health Research and Development / Danish Centre for Evaluation and Health Technology Assessment / Evaluation in Healthcare / Canadian Coordinating Office for Health Technology Assessment / Canadian Coordinating Office for Heath Technology Assessment / Australia’s Medical Services Advisory Committee / National Association of Statutory Health Insurance Physicians / Catalan Agency for Health Technology Assessment / Medicare / HTA Israel Center for Technology Assessment / Alberta Heritage Foundation for Medical Research / Uppsala University Hospital / Health Technology Assessment Unit / Institute of Technology Assessment / National Coordinating Centre for Health Technology Assessment / Federal Social Insurance Office Switzerland / Austrian Academy of Sciences / Health Technology Assessment / PET Centre / Department of Health / NHS / Catalan Agency for Health Technology Assessment and Research / Norwegian Centre for Health Technology Assessment / Institute of Applied Health Sciences / Medical Services Advisory Committee / Ministry of Health / Belgian Knowledge Centre for Health Care / Danish Centre for Evaluation / University Hospital Department of Oncology / Nuclear Medicine / and University Hospital Department of Oncology / /
Person
John Hastings Australian / John Hastings / Elizabeth Adams / / /
Position
Federal Minister / Research Analyst / Head / general overview / Governor / Surveya Indication Oncology Head / /
Product
PET / /
ProvinceOrState
Quebec / Capital Territory / Ontario / /
Technology
potential beneficial diagnostic technologies / research protocol / tomography / MTU / high cost diagnostic technologies / diagnostic imaging / high cost diagnostic technology / /
International Journal of Technology Assessment in Health Care, 22:[removed]), 143–148. c 2006 Cambridge University Press. Printed in the U.S.A. Copyright Joint project of the international network of agencies for healt